Newsroom

Sight Sciences Files Lawsuit Against Ivantis for Patent Infringement

Sight Sciences Seeks Injunction Related to Hydrus® Microstent’s Infringement

read more +
Sight Sciences to Participate in the Morgan Stanley Global Healthcare Conference

MENLO PARK, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on developing and commercializing devices designed to address the underlying...

read more +
Sight Sciences Announces Publication of Favorable Two-Year Outcomes of Standalone Use of the OMNI® Surgical System in Mild to Moderate Open-Angle Glaucoma

Pioneering the Development of the Standalone MIGS Market, this Real-world data published in Clinical Ophthalmology show the safety, efficacy, and durability of effect of OMNI for use in a standalone procedure to reduce intraocular pressure and medication burden

read more +
Sight Sciences Reports Second Quarter 2021 Financial Results

MENLO PARK, Calif., August 12, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and...

read more +
Sight Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021

MENLO PARK, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) today announced it will report financial results for the second quarter 2021 after the market close...

read more +
Sight Sciences Announces Pricing of Initial Public Offering

Sight Sciences Announces Pricing of Initial Public Offering

read more +
Event: European Society of Cataract and Refractive Surgeons (ESCRS)

Event Details August 27-30 Amsterdam, Netherlands Contact Sight Sciences today to schedule a meeting.

read more +
Event: World Glaucoma Congress (WGC)

Event Details June 30- July 3 VIRTUAL Contact Sight Sciences today to schedule a meeting.

read more +